Phio Pharmaceuticals
About:
Phio Pharmaceuticals is a biotechnology company specializing in the application of RNAi therapies in immuno-oncology.
Website: https://phiopharma.com
Twitter/X: phio_pharma
Top Investors: OPKO Health, Lincoln Park Capital Fund, TRITON FUNDS LLC
Description:
Phio Pharmaceuticals is a biotechnology company specializing in the application of RNAi therapies in immuno-oncology. Its proprietary INTASYL technology is a platform for self-delivering RNAi immuno-oncology therapies. It is a patented platform from which unique patented compounds are created to silence genes that tumors use to evade the immune system.
$116M
$1M to $10M
Marlborough, Massachusetts, United States
2012-01-01
info(AT)phiopharma.com
Craig Mello, Michael Czech
11-50
2024-07-12
Public
© 2025 bioDAO.ai